Two Dose Levels of Privigen in Pediatric CIDP

Abroad (travel likely)RecruitingPHASE4

Conditions

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Phoenix Children's Hospital, Phoenix, Arizona, United States

  • Children's Hospital of Los Angeles, Los Angeles, California, United States

  • University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

  • Akron Children's Hospital, Akron, Ohio, United States

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Use Central Contact)
  • Le Bonheur Children's Hospital, Memphis, Tennessee, United States

  • Neurology Rare Disease Center, Flower Mound, Texas, United States

    Contact: Study coordinator (Use Central Contact)
  • Children's Specialty Group, Norfolk, Virginia, United States

  • Seattle Children's Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Central Contact)
Study leads
  • Study Director

    CSL Behring